Articles

Novo Nordisk Stock: The AI Case Wall Street May Be Missing

Eric Fry examines Novo Nordisk stock as an AI healthcare opportunity, weighing faster drug research, oral Wegovy, and competition.

AI Agents Need Guardrails. These 3 Stocks Could Benefit.

AI agent security is creating opportunities for Palo Alto, CrowdStrike, and Cloudflare. We examine paid adoption, competition, and revenue.

Anthropic IPO: Why the Stakes Go Far Beyond ANT Stock

The Anthropic IPO tests AI financing. We examine the stakes for Broadcom, Google and AMD, plus the risks of buying Anthropic stock.

5 Growth Stocks for an AI Market in Transition

Luke Lango examines five growth stocks in cybersecurity, software, and health care as AI data center spending faces mounting pressure.

Why 20% Earnings Growth Suddenly Isn’t Good Enough

Why are AI stocks falling despite strong earnings? See how shifting expectations are reshaping valuations and creating new opportunities.

How the Data Center Backlash Changes Where the Money Goes

Data center backlash is delaying projects, but AI demand is shifting capital toward the companies solving the buildout’s bottlenecks.

Is the AI Bubble About to Burst? 13 Signals We’re Watching

Our AI bubble checklist has 7 of 13 warning signals lit. Here’s why the boom looks late cycle – but hasn’t peaked yet.

Jensen Huang Is Out. What Happens to Nvidia Stock Now?

Jensen Huang is out at Nvidia. Louis Navellier explains what it means for NVDA stock, whether to hold, and what investors should watch next.

A Slowdown May Be Exactly What the AI Boom Needs

There's a reason professional athletes don't train at full speed every single day. If you push too hard for too long, you'll break like a…

Goldman, Citi and the $270 Million Fight Over Your Bank Deposit

Project Faro shows how banks are responding as stablecoins, AI agents and fintech apps make customer deposits easier to move.

How Jensen Huang’s Honeypot Scandal Could Broaden the AI Trade

Nvidia’s Jensen Huang scandal could shift AI spending toward AMD, Broadcom, and Marvell. Luke Lango explains the opportunity, and why he’s staying patient.

Finding 2027’s Best Stocks May Require Letting Go of 2026’s Winners

Market leadership is shifting into 2027, making stock selection more important as investors follow fundamentals into new sectors.

A Historically Strong Post-Midterm Market Could Make 2027 a Stock-Picker’s Year

Stocks have historically rallied after midterms, while strong earnings and shifting market leadership set the stage for a selective 2027.

Why I’m Buying the AI Selloff: My Top Picks for 2027

Luke Lango examines the AI selloff, why chip suppliers may weather slower data-center construction, and the opportunities and risks in Nvidia, AMD, and Nebius.

America’s Military Rebuild Starts With a Manufacturing Problem

America’s military rebuild needs factories, parts, and proven suppliers. See why RTX is a defense stock to watch as air-defense orders grow.

The Lockheed Martin Business I’d Watch More Closely Than the F-35

Lockheed Martin's $58.6 billion PAC-3 award shows how America's rearmament push is turning defense spending into factory expansion.

Why I’m Watching This Missile Defense Giant as America Rearms for Drone Warfare

Explore RTX’s role in missile replenishment and counter-drone defense—and the investment thesis behind Luke Lango’s Rearming America briefing.

AI Has Entered the Chain of Command

Sovereign AI is moving from policy to procurement as the Pentagon builds around autonomy, secure compute, cyber defense and robotics.

DoorDash’s Five-Minute Drone Test Opens a Much Bigger AI Story

DoorDash’s new drone shows why physical AI investing extends beyond robots to the companies solving power and production constraints.